Aequim Alternative Investments LP - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 60 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Aequim Alternative Investments LP ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q2 2021$10,088,000
-2.1%
7,609,0000.0%0.43%
-34.9%
Q1 2021$10,305,000
+148.0%
7,609,000
+153.6%
0.66%
+20.3%
Q3 2020$4,155,000
-86.5%
3,000,000
-87.5%
0.55%
-89.2%
Q1 2020$30,877,000
+168.0%
24,000,000
+220.0%
5.11%
+138.4%
Q4 2019$11,522,0007,500,0002.14%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q3 2020
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders